Terazosin Capsule
Product Images NDC 59746-385

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 59746-385). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jubilant Cadista Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 mg Label (59746 383 06)

This is a description of a medication with the NDC code 59746-383-06. The medication comes in the form of capsules containing Terazosin Hydrochbride. The capsules are prescribed for medical use, and there is a caution to store them at a controlled room temperature, away from light and moisture. The medication is manufactured by Cadistay Pharmaceuticals, and a bottle contains 100 capsules.*

FDA Label Image

2 mg Label (59746 384 06)

This is a medication description for Terazosin Hydrochloride, available in capsule form and manufactured by Cadista Pharmaceuticals. Each capsule contains Terazosin Hydrochloride and should be stored in a light-resistant container at controlled room temperature to protect from light and moisture. The package contains 100 capsules, and the prescribing information is included.*

FDA Label Image

5 mg Label (59746 385 06)

NDC 59746-385-06 is a prescription medication in capsule form containing Torazosin Hydrochloride. Each capsule is made up of Terazosin and is stored in a tightly sealed, high-resistant container as defined by USP guidelines. The capsules should be protected from light and moisture and stored at a temperature of 20-25°C. The drug is manufactured by Cadista and Jubilant Cacta Pharmaceuticals and is sold in packages containing 100 capsules.*

FDA Label Image

10 mg Label (59746 386 06)

Each capsule contains 10 mg of Terazosin Hydrochloride and is manufactured by CADISTA Pharmaceuticas. The capsules should be dispensed in a light-resistant container as defined in USP, stored at a controlled room temperature of 20-25°C (68-77°F), and protected from moisture. Full prescribing information can be found in the package insert.*

FDA Label Image

Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)

FDA Label Image

Figure 1 (Terazosin Hydrochloride Capsules 2)

FDA Label Image

Figure 2 (Terazosin Hydrochloride Capsules 3)

FDA Label Image

Figure 3 (Terazosin Hydrochloride Capsules 4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.